• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性肾损伤病例的严重程度和死亡率与性别二态性的关系。

Association of severity and mortality of Covid-19 cases among acute kidney injury and sexual dimorphism.

机构信息

Department of Urology, King George's Medical University, Chowk, Lucknow, Uttar Pradesh, 226003, India.

Department of Thoracic Surgery, King George's Medical University, Lucknow, UP, 226003, India.

出版信息

Mol Biol Rep. 2022 Jul;49(7):6753-6762. doi: 10.1007/s11033-022-07308-1. Epub 2022 Mar 6.

DOI:10.1007/s11033-022-07308-1
PMID:35249167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8898193/
Abstract

INTRODUCTION

The outbreak of coronavirus disease 2019 (Covid-19) severely impacted global health and economic status. The native receptor-ligand interaction of Angiotensin-converting enzyme 2 (ACE2) and S protein induces host cell pathogenesis via immunosuppression.

MATERIAL AND METHODS

The emerging evidence reports the sex disparity in Covid-19 induced mortality rate which affects abundantly men population. Although the biological interaction of Covid-19 with receptor upregulates the viral genome protein interactions and initiates the predictive multiorgan failure followed by acute kidney injury (AKI) in Covid-19 infected male population.

CONCLUSION

Besides, the knowledge and lessons learned from the study depict that cellular and molecular links may explain the risk and severity of Covid-19 and AKI in the male population and lead to management of Covid-19 induced AKI. Therefore, this review explored the pathways associated with the pathogenesis of two diseased conditions with sex disparity.

摘要

简介

2019 年冠状病毒病(COVID-19)的爆发严重影响了全球健康和经济状况。血管紧张素转换酶 2(ACE2)和 S 蛋白的天然受体-配体相互作用通过免疫抑制引起宿主细胞发病机制。

材料与方法

新出现的证据报告了 COVID-19 导致的死亡率存在性别差异,这对男性人口产生了巨大影响。尽管 COVID-19 与受体的生物学相互作用上调了病毒基因组蛋白的相互作用,并在 COVID-19 感染的男性人群中引发了预测性多器官衰竭,随后是急性肾损伤(AKI)。

结论

此外,从研究中获得的知识和经验教训表明,细胞和分子联系可以解释 COVID-19 和 AKI 在男性人群中的风险和严重程度,并导致 COVID-19 诱导的 AKI 的管理。因此,本综述探讨了与两种性别差异疾病发病机制相关的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb2/8898193/8b624de2c826/11033_2022_7308_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb2/8898193/7d4b492e8d05/11033_2022_7308_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb2/8898193/8b624de2c826/11033_2022_7308_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb2/8898193/7d4b492e8d05/11033_2022_7308_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb2/8898193/8b624de2c826/11033_2022_7308_Fig2_HTML.jpg

相似文献

1
Association of severity and mortality of Covid-19 cases among acute kidney injury and sexual dimorphism.急性肾损伤病例的严重程度和死亡率与性别二态性的关系。
Mol Biol Rep. 2022 Jul;49(7):6753-6762. doi: 10.1007/s11033-022-07308-1. Epub 2022 Mar 6.
2
Androgens, the kidney, and COVID-19: an opportunity for translational research.雄激素、肾脏与 COVID-19:转化研究的契机。
Am J Physiol Renal Physiol. 2021 Feb 1;320(2):F243-F248. doi: 10.1152/ajprenal.00601.2020. Epub 2021 Jan 19.
3
Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.单细胞 RNA 测序分析人类肾脏揭示 ACE2 受体的存在:COVID-19 感染的潜在途径。
Mol Genet Genomic Med. 2020 Oct;8(10):e1442. doi: 10.1002/mgg3.1442. Epub 2020 Aug 3.
4
Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.新型冠状病毒肺炎患者的急性肾损伤:城市内医院的经验及政策影响。
Am J Nephrol. 2020;51(10):786-796. doi: 10.1159/000511160. Epub 2020 Oct 2.
5
COVID-19 and Kidney Disease: Update on Epidemiology, Clinical Manifestations, Pathophysiology and Management.2019冠状病毒病与肾脏疾病:流行病学、临床表现、病理生理学及管理的最新进展
J Coll Physicians Surg Pak. 2020 Jun;30(6):19-25. doi: 10.29271/jcpsp.2020.Supp1.S19.
6
Acute Kidney Injury Can Predict In-Hospital Mortality in Elderly Patients with COVID-19 in the ICU: A Single-Center Study.急性肾损伤可预测 ICU 中 COVID-19 老年患者的院内死亡率:一项单中心研究。
Clin Interv Aging. 2020 Nov 9;15:2095-2107. doi: 10.2147/CIA.S273720. eCollection 2020.
7
SARS-CoV-2 Infection and the Kidneys: An Evolving Picture.严重急性呼吸综合征冠状病毒 2 感染与肾脏:不断变化的图景。
Adv Exp Med Biol. 2021;1327:107-118. doi: 10.1007/978-3-030-71697-4_8.
8
A survey on acute kidney injury in severely and critically ill COVID-19 patients without chronic kidney disease.一项关于无慢性肾脏病的重症 COVID-19 患者急性肾损伤的调查。
Ann Palliat Med. 2021 Jun;10(6):6198-6207. doi: 10.21037/apm-20-2170. Epub 2021 May 17.
9
Gender and Ethnic Disparities of Acute Kidney Injury in COVID-19 Infected Patients: A Literature Review.新型冠状病毒感染患者急性肾损伤的性别和种族差异:文献综述。
Front Cell Infect Microbiol. 2022 Jan 13;11:778636. doi: 10.3389/fcimb.2021.778636. eCollection 2021.
10
Potential Mechanisms of the SARS-CoV-2-induced AKI Progression to CKD: A Forward-Looking Perspective.SARS-CoV-2 诱导的 AKI 进展为 CKD 的潜在机制:前瞻性观点。
Iran J Kidney Dis. 2021 Jul;15(4):243-255.

引用本文的文献

1
Renal outcomes in IgA nephropathy following inactivated SARS-CoV-2 vaccination.灭活 SARS-CoV-2 疫苗接种后 IgA 肾病的肾脏结局。
Clin Exp Nephrol. 2024 Jan;28(1):23-30. doi: 10.1007/s10157-023-02398-y. Epub 2023 Sep 15.

本文引用的文献

1
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.一项国际、多中心、随机、双盲、安慰剂对照的 III 期临床试验中,重组新型冠状病毒疫苗(腺病毒 5 型载体)在 18 岁及以上成年人中的单次剂量的最终疗效分析、中期安全性分析和免疫原性。
Lancet. 2022 Jan 15;399(10321):237-248. doi: 10.1016/S0140-6736(21)02753-7. Epub 2021 Dec 23.
2
Sex differences in the immune response to acute COVID-19 respiratory tract infection.急性 COVID-19 呼吸道感染的免疫反应中的性别差异。
Biol Sex Differ. 2021 Dec 20;12(1):66. doi: 10.1186/s13293-021-00410-2.
3
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.NVX-CoV2373 在美墨成年人群中的疗效和安全性。
N Engl J Med. 2022 Feb 10;386(6):531-543. doi: 10.1056/NEJMoa2116185. Epub 2021 Dec 15.
4
BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial).BCG 疫苗接种以减轻医护人员 COVID-19 的影响:一项随机对照试验(BRACE 试验)方案。
BMJ Open. 2021 Oct 28;11(10):e052101. doi: 10.1136/bmjopen-2021-052101.
5
Associated pathogenesis of bladder cancer and SARS-CoV-2 infection: a treatment strategy.膀胱癌与新型冠状病毒肺炎感染的相关发病机制:一种治疗策略。
Virusdisease. 2021 Dec;32(4):613-615. doi: 10.1007/s13337-021-00742-y. Epub 2021 Sep 24.
6
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.AZD1222(ChAdOx1 nCoV-19)新冠疫苗的 3 期安全性和疗效。
N Engl J Med. 2021 Dec 16;385(25):2348-2360. doi: 10.1056/NEJMoa2105290. Epub 2021 Sep 29.
7
Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina.Gam-COVID-Vac(卫星V疫苗)第一剂对60-79岁患者中确诊的SARS-CoV-2感染、住院和死亡减少的有效性:阿根廷的一项回顾性队列研究
EClinicalMedicine. 2021 Oct;40:101126. doi: 10.1016/j.eclinm.2021.101126. Epub 2021 Sep 12.
8
Vaccine Development against COVID-19: Study from Pre-Clinical Phases to Clinical Trials and Global Use.针对新型冠状病毒肺炎的疫苗研发:从临床前阶段到临床试验及全球应用的研究
Vaccines (Basel). 2021 Jul 29;9(8):836. doi: 10.3390/vaccines9080836.
9
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.一种灭活全病毒 SARS-CoV-2 疫苗(克尔来福)的有效性和安全性:在土耳其进行的一项双盲、随机、安慰剂对照、3 期临床试验的中期结果。
Lancet. 2021 Jul 17;398(10296):213-222. doi: 10.1016/S0140-6736(21)01429-X. Epub 2021 Jul 8.
10
Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes.雄激素对肺内 AR、TMPRSS2 和 ACE2 的调节作用及其对性别差异 COVID-19 结局的影响。
Sci Rep. 2021 May 27;11(1):11130. doi: 10.1038/s41598-021-90491-1.